The Effect of Acupressure on Restless Legs Syndrome and Pruritus in Patients Undergoing Hemodialysis
RLS/CKD-aP
"Effect of Combined Traditional and Paraspinal Acupressure on Restless Legs Syndrome and Pruritus in Patients Undergoing Hemodialysis: A Randomized Controlled Trial
1 other identifier
interventional
70
1 country
1
Brief Summary
This randomized controlled trial aims to evaluate the effect of combined traditional and paraspinal acupressure on restless legs syndrome and pruritus among patients undergoing hemodialysis. Participants will be randomly assigned to either an intervention group receiving the acupressure intervention in addition to routine hemodialysis care or a control group receiving routine care only. The severity of restless legs syndrome and pruritus will be assessed at predetermined time points using validated assessment tools. The study aims to determine whether the combined acupressure intervention is effective in reducing restless legs syndrome and pruritus symptoms in patients undergoing hemodialysis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 5, 2026
CompletedFirst Posted
Study publicly available on registry
September 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 1, 2027
September 11, 2026
September 1, 2026
7 months
September 5, 2026
September 5, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Restless Legs Syndrome Severity Assessed by the International Restless Legs Syndrome Study Group Rating Scale (IRLS)
The questionnaire consisted of 10 items, each of which had a scale ranging from 0 (no impact) to 4 (very severe impact). RLS severity was defined as mild (0-10 points), moderate (11-20 points), severe (21-30 points), or very severe (31-40 points).
Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention
Change in Pruritus Severity Assessed by the 5-D Itch Scale
Pruritus severity will be assessed using the 5-D Itch Scale, which evaluates five dimensions of itching: duration, degree, direction, disability, and distribution. The total score ranges from 5 to 25, with higher scores indicating greater severity and impact of pruritus
Baseline (before intervention), 1 month after initiation of the intervention, and 2 months after initiation of the intervention
Study Arms (2)
intervention group (Vibration assisted acupressure)
EXPERIMENTALParticipants in this group will receive vibration-assisted acupressure using an acupressure device applied to selected acupoints in addition to routine hemodialysis care. The intervention will be administered according to the study protocol to evaluate its effects on restless legs syndrome and pruritus among patients undergoing
CONTROL GROUP
NO INTERVENTIONParticipants will receive routine hemodialysis care without the acupressure intervention
Interventions
Vibration-assisted acupressure will be applied to selected traditional and paraspinal acupoints using a handheld vibration device. The intervention is designed to reduce the severity of restless legs syndrome and pruritus in patients undergoing hemodialysis. It will be administered according to a predefined intervention protocol in addition to routine hemodialysis care
Eligibility Criteria
You may qualify if:
- Patients more than 18 years old on hemodialysis treatment for more than 2 sessions per week.
- The patients on hemodialysis for more than 3 months
- The patients who complain of restless leg syndrome and pruritus.
- RLS diagnosis meeting the diagnostic criteria defined by the International Restless Legs Syndrome Study Group (IRLSSG).
- At least moderate RLS symptoms (IRLS - total score ≥ 11)
- Patients who score more than five on the 5D Pruritus scale.
- Patient with a history of pruritus for more than 3 months.
You may not qualify if:
- Patients with impaired skin integrity.
- Patients with skin lesions in areas involved in acupressure therapy.
- Patients with neurological deficits as perception of pain, may differ from other patients.
- Patients with a body mass index (BMI) of more than \> 30 kg/m².
- Patients with malignancy.
- Patients with Jaundice.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Al-Hussien Hemodialysis center
Dhi-Qar, Dhi Qar, 64001, Iraq
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hakima Shaker Hassan, Assist prof
College of Nursing/ University of Baghdad
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PHD student
Study Record Dates
First Submitted
September 5, 2026
First Posted
September 11, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
March 30, 2027
Study Completion (Estimated)
April 1, 2027
Last Updated
September 11, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share